![](/images/graphics-bg.png)
Treatment of Neuroendocrine Tumor Liver Metastases
Joint Authors
Lewis, Mark A.
Hobday, Timothy J.
Source
International Journal of Hepatology
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-11-25
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
In the care of patients with hepatic neuroendocrine metastases, medical oncologists should work in multidisciplinary fashion with surgeons, interventional radiologists, and radiation oncologists to assess the potential utility of liver-directed and systemic therapies.
This paper addresses the various roles and evidence basis for cytoreductive surgery, thermal ablation (radiofrequency, microwave, and cryoablation), and embolization (bland embolization (HAE), chemoembolization (HACE), and radioembolization) as liver-directed therapies.
Somatostatin analogues, cytotoxic chemotherapy, and the newer agents everolimus and suntinib are discussed as a means for controlling intra- and extrahepatic disease, along with peptide receptor radiotherapy (PRRT).
Finally, the experience with orthotopic liver transplant for neuroendocrine tumors is described.
American Psychological Association (APA)
Lewis, Mark A.& Hobday, Timothy J.. 2012. Treatment of Neuroendocrine Tumor Liver Metastases. International Journal of Hepatology،Vol. 2012, no. 2012, pp.1-12.
https://search.emarefa.net/detail/BIM-512717
Modern Language Association (MLA)
Lewis, Mark A.& Hobday, Timothy J.. Treatment of Neuroendocrine Tumor Liver Metastases. International Journal of Hepatology No. 2012 (2012), pp.1-12.
https://search.emarefa.net/detail/BIM-512717
American Medical Association (AMA)
Lewis, Mark A.& Hobday, Timothy J.. Treatment of Neuroendocrine Tumor Liver Metastases. International Journal of Hepatology. 2012. Vol. 2012, no. 2012, pp.1-12.
https://search.emarefa.net/detail/BIM-512717
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-512717